Entering the Eastern and Central Europe markets: Aston Group has established an office in Budapest

Publication date: 8 february 2017

Aston Group continues to grow and expand. At the end of the last year, the company opened a representative office in Budapest, Hungary.

On February 3, 2017, Aston Group together with its Hungarian partner Szinapszis hosted a business breakfast at the Continental Hotel Zara on this occasion. The event was attended by the representatives of the world's leading pharmaceutical manufacturers such as MSD, Pfizer, Fresenius, Celgene, Sanofi, Bayer, Novartis, FGN, Ikelosz and Berlin-Chemie Menarini.

Anton Artyomov, CEO, Aston Group, made a presentation titled Patient Centricity:  New Strategic Focus for Pharma.

In his report he pointed out that “for over 15 years, the company has contributed to the evolution of a patient-centered healthcare model. We have always been in close communication with the medical community and industry stakeholders in developing real world evidence to support decision-making. Together with the drug manufacturers we have been introducing new services aimed at improving the quality of patients’ life.

As we earlier have branched out to Kazakhstan market, we got yet another proof that the consistent approach we have applied to industry improvement in Russia is universally appropriate regardless of the differences in healthcare systems. And we have confidence that it is replicable in the European healthcare markets as well.”